nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—OPRD1—forebrain—attention deficit hyperactivity disorder	0.0443	0.128	CbGeAlD
Sufentanil—OPRK1—forebrain—attention deficit hyperactivity disorder	0.0425	0.123	CbGeAlD
Sufentanil—OPRM1—forebrain—attention deficit hyperactivity disorder	0.0302	0.0876	CbGeAlD
Sufentanil—OPRD1—nervous system—attention deficit hyperactivity disorder	0.0241	0.0697	CbGeAlD
Sufentanil—OPRD1—central nervous system—attention deficit hyperactivity disorder	0.0232	0.0671	CbGeAlD
Sufentanil—OPRK1—nervous system—attention deficit hyperactivity disorder	0.0231	0.0669	CbGeAlD
Sufentanil—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.0222	0.0644	CbGeAlD
Sufentanil—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.0217	0.0629	CbGeAlD
Sufentanil—OPRM1—midbrain—attention deficit hyperactivity disorder	0.02	0.0578	CbGeAlD
Sufentanil—OPRD1—brain—attention deficit hyperactivity disorder	0.0184	0.0533	CbGeAlD
Sufentanil—OPRK1—brain—attention deficit hyperactivity disorder	0.0176	0.0511	CbGeAlD
Sufentanil—OPRM1—nervous system—attention deficit hyperactivity disorder	0.0164	0.0476	CbGeAlD
Sufentanil—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.0158	0.0458	CbGeAlD
Sufentanil—OPRD1—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0128	0.0196	CbGpPWpGaD
Sufentanil—OPRM1—brain—attention deficit hyperactivity disorder	0.0125	0.0364	CbGeAlD
Sufentanil—OPRK1—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0112	0.0172	CbGpPWpGaD
Sufentanil—OPRK1—Mecp2 and Associated Rett Syndrome—BDNF—attention deficit hyperactivity disorder	0.0108	0.0164	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0095	0.0145	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.0086	0.0131	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00798	0.0122	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00782	0.0119	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00776	0.0119	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00754	0.0115	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.007	0.0107	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00686	0.0105	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00684	0.0104	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00681	0.0104	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0067	0.0102	CbGpPWpGaD
Sufentanil—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00668	0.0194	CbGeAlD
Sufentanil—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00643	0.0187	CbGeAlD
Sufentanil—OPRM1—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00637	0.00973	CbGpPWpGaD
Sufentanil—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00602	0.00918	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.006	0.00915	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00591	0.00903	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00587	0.00897	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00584	0.00891	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00579	0.00885	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00575	0.00878	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00542	0.00827	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00521	0.00795	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00512	0.00782	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.0051	0.00779	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0051	0.00779	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00507	0.00774	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00496	0.00758	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00475	0.00725	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00474	0.00723	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00464	0.00709	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.0046	0.00702	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00457	0.00697	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00452	0.0069	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00448	0.00683	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00447	0.00683	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00446	0.00681	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0044	0.00672	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00439	0.0067	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00433	0.00661	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00427	0.00651	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00419	0.0064	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00416	0.00634	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00415	0.00634	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00414	0.00632	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00407	0.00622	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00406	0.0062	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00403	0.00615	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00402	0.00613	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00398	0.00608	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00396	0.00605	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00391	0.00597	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00386	0.00589	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00386	0.00589	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00386	0.00589	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00385	0.00587	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00378	0.00577	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00378	0.00577	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00377	0.00576	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00374	0.00571	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00368	0.00561	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00365	0.00558	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00364	0.00556	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00363	0.00554	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00359	0.00548	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00356	0.00543	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00355	0.00542	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00354	0.0054	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00351	0.00536	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00349	0.00533	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00344	0.00525	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00341	0.0052	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00338	0.00516	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00335	0.00511	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00331	0.00505	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00331	0.00505	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0033	0.00504	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00326	0.00498	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00325	0.00496	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0032	0.00489	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00316	0.00483	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00315	0.00481	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00311	0.00475	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00311	0.00474	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0031	0.00473	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00309	0.00472	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00308	0.0047	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00307	0.00468	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00301	0.00459	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00295	0.00451	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00294	0.00449	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0029	0.00442	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00288	0.0044	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00287	0.00439	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00286	0.00436	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0028	0.00427	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00278	0.00425	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00274	0.00418	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00271	0.00414	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00271	0.00413	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0027	0.00412	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0027	0.00412	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00267	0.00408	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00266	0.00406	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00263	0.00401	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00262	0.004	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00262	0.004	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00258	0.00394	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00253	0.00386	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00252	0.00385	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00252	0.00384	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00245	0.00374	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00244	0.00372	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0024	0.00366	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00237	0.00362	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00237	0.00362	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00235	0.00359	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00234	0.00358	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00231	0.00353	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0023	0.0035	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00229	0.0035	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00221	0.00337	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00218	0.00333	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00214	0.00326	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00213	0.00325	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00206	0.00315	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00206	0.00315	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00203	0.0031	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00203	0.00309	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.002	0.00306	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.002	0.00306	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.002	0.00305	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00198	0.00302	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00194	0.00296	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00186	0.00285	CbGpPWpGaD
Sufentanil—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00185	0.00282	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00184	0.0028	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00181	0.00277	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00176	0.00269	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00175	0.00267	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00175	0.00267	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00174	0.00266	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00172	0.00262	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00162	0.00248	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00161	0.00246	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00159	0.00243	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00159	0.00242	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00158	0.00241	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00157	0.0024	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00155	0.00236	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00155	0.00236	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00155	0.00236	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00153	0.00234	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00153	0.00233	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00152	0.00232	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00148	0.00226	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00147	0.00225	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00143	0.00218	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00142	0.00217	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00142	0.00217	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.0014	0.00214	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00139	0.00212	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00139	0.00212	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00138	0.00211	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00138	0.0021	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00136	0.00208	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00136	0.00207	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00136	0.00207	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00134	0.00205	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00134	0.00204	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00133	0.00203	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00131	0.00199	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00129	0.00198	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00129	0.00197	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00129	0.00197	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00125	0.00191	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00125	0.0019	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00123	0.00188	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00122	0.00186	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0012	0.00184	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00118	0.00179	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00117	0.00179	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00117	0.00178	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00115	0.00175	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00115	0.00175	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00113	0.00173	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00113	0.00173	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00112	0.00172	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00109	0.00167	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00107	0.00164	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00106	0.00162	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00105	0.00161	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00104	0.00159	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00103	0.00157	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000996	0.00152	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000989	0.00151	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000982	0.0015	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000975	0.00149	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000957	0.00146	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00094	0.00143	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000937	0.00143	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000905	0.00138	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000873	0.00133	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000871	0.00133	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000844	0.00129	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000829	0.00127	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000822	0.00125	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000819	0.00125	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000794	0.00121	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000793	0.00121	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000764	0.00117	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000763	0.00116	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00074	0.00113	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000738	0.00113	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000727	0.00111	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000718	0.0011	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000694	0.00106	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00067	0.00102	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000669	0.00102	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000646	0.000985	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000625	0.000954	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000615	0.000938	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000607	0.000926	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000565	0.000863	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000534	0.000816	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000469	0.000715	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000404	0.000617	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000396	0.000604	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000283	0.000432	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000279	0.000426	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000279	0.000426	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000275	0.000419	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000255	0.00039	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000248	0.000379	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000223	0.000341	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000212	0.000324	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00021	0.00032	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000169	0.000258	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000168	0.000256	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	7.25e-05	0.000111	CbGpPWpGaD
